Key result
Ellagic acid at 30 μM inhibited LPS-induced PGE2 release from human monocytes by 84-93% through the suppression of COX-2, mPGEs-1, and cPLA2a protein expression.
Why the study?
Does ellagic acid inhibit PGE2 release and prostaglandin-synthesising enzyme expression in human monocytes?
Does ellagic acid inhibit PGE2 release and prostaglandin-synthesising enzyme expression in human monocytes?
Ellagic acid exerts anti-inflammatory effects in human monocytes by suppressing the expression of key enzymes involved in PGE2 synthesis rather than directly inhibiting their activity.
Answers are grounded in this paper and cite their sources.
May support ellagic acid as an anti-inflammatory agent in vitro; leaves open translation to clinical use.
Ellagic acid, a natural polyphenol found in certain fruits, nuts and vegetables, has in recent years been the subject of intense research within the fields of cancer and inflammation. Pain, fever and swelling, all typical symptoms of inflammation, are ascribed to elevated levels of PGE2. In the present study, we have investigated the effects of ellagic acid on PGE2 release and on prostaglandin-synthesising enzymes in human monocytes. Ellagic acid was found to inhibit Ca ionophore A23187-, phorbol myristate acetate- and opsonised zymosan-induced release of PGE2 from monocytes pre-treated with the inflammatory agent lipopolysaccharide. Ellagic acid suppressed the lipopolysaccharide-induced increase in protein expression of cyclo-oxygenase-2 (COX-2), microsomal PGE synthase-1 (mPGEs-1) and cytosolic phospholipase A2alpha (cPLA2alpha), while it had no effect on the constitutively expressed COX-1 protein. Ellagic acid had no apparent inhibitory effect on these enzymes when the activities were determined in cell-free assays. We conclude that the inhibitory effect of ellagic acid on PGE2 release from monocytes is due to a suppressed expression of COX-2, mPGEs-1 and cPLA2alpha, rather than a direct effect on the activities of these enzymes.
No takes yet. Share an insight, caveat, or question.
Karlsson et al. (2009) studied Inflammation (in vitro model). Ellagic acid vs. LPS alone (control) was evaluated on PGE2 release induced by A23187, PMA, or opsonised zymosan after LPS pre-treatment (83.9% to 92.7% inhibition, p=<0.05). Ellagic acid at 30 μM inhibited LPS-induced PGE2 release from human monocytes by 84-93% through the suppression of COX-2, mPGEs-1, and cPLA2a protein expression.
Synapse has enriched 10 related papers. Consider them for comparative context: